MiNK Therapeutics Statistics
Total Valuation
INKT has a market cap or net worth of $20.72 million. The enterprise value is $19.01 million.
Important Dates
The last earnings date was Thursday, November 14, 2024, before market open.
Earnings Date | Nov 14, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
INKT has 39.55 million shares outstanding. The number of shares has increased by 6.74% in one year.
Current Share Class | 39.55M |
Shares Outstanding | 39.55M |
Shares Change (YoY) | +6.74% |
Shares Change (QoQ) | +6.44% |
Owned by Insiders (%) | 19.62% |
Owned by Institutions (%) | 2.15% |
Float | 10.02M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.89
Current Ratio | 0.89 |
Quick Ratio | 0.86 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -120.36% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -$444,526 |
Employee Count | 31 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.60% in the last 52 weeks. The beta is 0.09, so INKT's price volatility has been lower than the market average.
Beta (5Y) | 0.09 |
52-Week Price Change | -47.60% |
50-Day Moving Average | 0.69 |
200-Day Moving Average | 0.85 |
Relative Strength Index (RSI) | 30.63 |
Average Volume (20 Days) | 53,332 |
Short Selling Information
The latest short interest is 43,005, so 0.11% of the outstanding shares have been sold short.
Short Interest | 43,005 |
Short Previous Month | 50,694 |
Short % of Shares Out | 0.11% |
Short % of Float | 0.43% |
Short Ratio (days to cover) | 1.10 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -14.29M |
Pretax Income | -20.59M |
Net Income | -13.78M |
EBITDA | -14.07M |
EBIT | -14.29M |
Earnings Per Share (EPS) | -$0.38 |
Full Income Statement Balance Sheet
The company has $6.33 million in cash and $4.61 million in debt, giving a net cash position of $1.72 million or $0.04 per share.
Cash & Cash Equivalents | 6.33M |
Total Debt | 4.61M |
Net Cash | 1.72M |
Net Cash Per Share | $0.04 |
Equity (Book Value) | -17.55M |
Book Value Per Share | -0.44 |
Working Capital | -823,773 |
Full Balance Sheet Cash Flow
Operating Cash Flow | -10.86M |
Capital Expenditures | n/a |
Free Cash Flow | -10.86M |
FCF Per Share | -$0.27 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |